Security Snapshot

ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share (ACHV) Institutional Ownership

CUSIP: 004468500

13F Institutional Holders and Ownership History from Q3 2020 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

89

Shares (Excl. Options)

83.19MFull value: 83,191,490 · shares · 30 Sep 2026

Price

$8.09

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+11,035,401
Value change
+$91,607,275
Number of holders
89
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
105,808,923
SEC-reported price per share
$7.19
Insider filing price
$7.19
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • ACHV - ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share is tracked under CUSIP 004468500.
  • 89 institutions reported positions in Q3 2026.
  • 13 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 111 to 89 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $538.75MFull value: $538,747,341 · USD · 30 Jun 2026
    to
    $669.4MFull value: $669,395,240 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 89 institutions filings for Q3 2026.

Open SEC evidence

Security key

004468500

13F reference period

Q3 2026

13F holders

89

13D/G owners

13

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
13
Security
ACHV
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
TPG GP A, LLC 13% $40,440,170 13,755,160 TPG GP A, LLC 17 Apr 2025
venBio Global Strategic Fund V, L.P. 10% $31,567,712 10,737,317 venBio Global Strategic Fund V, L.P. 15 Apr 2026
Paradigm Biocapital Advisors LP 9.2% $29,116,913 9,903,712 Paradigm BioCapital Advisors LP 17 Apr 2026
Logos Global Management LP 8.6% -14% $67,914,448 -$5,854,632 9,702,064 -7.9% Logos Global Management LP 30 Sep 2026
FRANKLIN RESOURCES INC 8.3% +35% $57,979,491 +$16,388,276 8,878,942 +39% Franklin Resources, Inc. 30 Jun 2026
Frazier Life Sciences Public Fund, L.P. 6.5% $19,479,817 6,625,788 Frazier Life Sciences Public Fund, L.P. 17 Apr 2026
Venrock Healthcare Capital Partners III, L.P. 5.2% 0% $39,559,840 5,502,064 0% Venrock Healthcare Capital Partners III, L.P. 30 Sep 2026
Janus Henderson Group Ltd. 5.4% $33,562,590 5,502,064 JANUS HENDERSON GROUP Ltd. 30 Jun 2026
Vivo Opportunity Fund Holdings, L.P. 5% $29,287,133 5,305,640 Vivo Opportunity, LLC 06 Jul 2026
BlackRock, Inc. 5.1% +450% $34,422,183 +$32,367,199 5,271,391 +1575% BlackRock, Inc. 30 Jun 2026
Alyeska Investment Group, L.P. 3.2% -40% $23,792,105 +$2,346,334 3,309,055 +11% Alyeska Investment Group, L.P. 30 Sep 2026
Contrarian Alpha, LP 4.9% $7,964,388 2,528,377 Parker Quillen 30 Sep 2025
VANGUARD GROUP INC 5% $4,086,493 1,717,014 The Vanguard Group 31 Mar 2025
As of 30 Sep 2026, 89 institutional investors reported holding
83.19MFull value: 83,191,490 · shares · 30 Sep 2026
shares of ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share (ACHV). This represents 79% of the company’s total
105.81MFull value: 105,808,923 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
71%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Frazier Life Sciences Management, L.P. 7.2% 7,614,836 1.5% $61,604,023
TPG GP A, LLC 6.5% 6,877,580 1.4% $55,639,622
Logos Global Management LP 5.6% 5,951,032 2.8% $48,143,849
venBio Partners LLC 5.6% 5,914,720 9.6% $47,850,085
Venrock Adviser, LLC 5.2% 5,502,064 2.2% $44,511,698
Paradigm Biocapital Advisors LP 4.7% 4,951,856 0.8% $40,060,515
Propel Bio Management, LLC 3.7% 3,864,148 17% $31,260,957
MARSHALL WACE, LLP 3.6% 3,770,313 0.03% $30,501,830
STATE STREET CORP 3.5% 3,718,240 0% $30,080,562
EVENTIDE ASSET MANAGEMENT, LLC 3.4% 3,571,721 0.4% $28,895,223
VANGUARD CAPITAL MANAGEMENT LLC 3.3% 3,480,234 0% $28,155,093
Vivo Capital, LLC 2.6% 2,751,032 2.4% $22,255,849
Janus Henderson Group Ltd. 2.6% 2,751,032 0.01% $22,255,849
ORBIMED ADVISORS LLC 2.2% 2,344,200 0.35% $18,964,578
GEODE CAPITAL MANAGEMENT, LLC 2% 2,156,709 0% $17,451,896
Boxer Capital Management, LLC 2% 2,150,000 1.5% $17,393,500
WELLINGTON MANAGEMENT GROUP LLP 1.6% 1,648,859 0% $13,339,269
Alyeska Investment Group, L.P. 0.92% 975,722 0.02% $7,893,591
LPL Financial LLC 0.92% 973,585 0% $7,876,303
Simplify Asset Management Inc. 0.88% 932,105 0.13% $7,540,729
Spruce Street Capital LP 0.7% 736,637 0.95% $5,959,393
VANGUARD PORTFOLIO MANAGEMENT LLC 0.69% 735,325 0% $5,948,779
VANGUARD FIDUCIARY TRUST CO 0.59% 620,907 0% $5,023,138
RAYMOND JAMES FINANCIAL INC 0.55% 583,491 0% $4,720,443
MERCER GLOBAL ADVISORS INC /ADV 0.52% 550,551 0.01% $4,453,961

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
25
Headline period
Q3 2026
Rows shown
1-25 of 25
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 83,191,490 $669,395,240 +$91,607,275 $8.09 89
2026 Q2 82,509,056 $538,747,341 +$386,629,895 $6.53 111
2026 Q1 21,523,954 $63,555,449 -$6,062,639 $2.94 79
2025 Q4 23,239,545 $115,291,318 +$36,552,641 $4.97 77
2025 Q3 15,541,415 $48,917,159 -$26,338,868 $3.15 65
2025 Q2 26,238,674 $59,299,106 +$26,395,211 $2.26 64
2025 Q1 14,388,656 $38,412,610 -$6,420,566 $2.67 72
2024 Q4 16,340,748 $57,510,675 -$2,280,524 $3.52 70
2024 Q3 16,929,998 $81,217,159 +$2,394,591 $4.74 64
2024 Q2 12,513,128 $58,811,518 +$9,414,756 $4.70 54
2024 Q1 10,495,260 $47,701,835 +$35,368,247 $4.54 39
2023 Q4 2,727,493 $11,236,940 -$1,729,113 $4.12 29
2023 Q3 3,117,219 $13,403,691 -$2,279,792 $4.30 35
2023 Q2 3,562,232 $18,487,663 +$5,645,131 $5.19 38
2023 Q1 2,470,554 $16,600,668 +$3,392,110 $6.80 31
2022 Q4 1,999,698 $4,902,826 -$458,841 $2.45 27
2022 Q3 2,121,733 $7,001,230 +$176,107 $3.30 28
2022 Q2 2,043,015 $9,968,000 -$109,417 $4.88 31
2022 Q1 1,932,821 $14,633,000 -$2,149 $7.57 33
2021 Q4 1,918,795 $14,925,000 +$535,636 $7.78 26
2021 Q3 1,782,658 $15,149,000 -$1,185,059 $8.50 30
2021 Q2 1,948,272 $17,498,000 +$7,592,533 $8.98 28
2021 Q1 1,007,113 $11,662,000 +$6,322,912 $11.58 16
2020 Q4 493,003 $3,994,000 +$307,274 $8.10 14
2020 Q3 452,590 $3,789,000 +$3,789,000 $8.37 12
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .